Biosceptre attending J.P. Morgan Healthcare Conference in January 2020
Biosceptre will be attending the J.P. Morgan Healthcare Conference, January [...]
Biosceptre Board Changes as result of Sir Gregory Winter’s Nobel Prize
On behalf of Biosceptre we would like to congratulate Sir [...]
Biosceptre wins Gold Medal at China’s largest event for promoting innovation and entrepreneurship
Upon invitation from our lead investor Tuspark S&T, Biosceptre recently [...]
Congratulations to Sir Greg Winter on award of Nobel Prize for Chemistry 2018
Biosceptre congratulates the chair of our Science Advisory Board and [...]
Initiation of Biosceptre’s Phase 1 Clinical Trial for First-in-Class Oncology Vaccine BIL06v
Biosceptre has initiated its Phase I clinical trial of the [...]
Biosceptre Paper published by Oncogene
A paper describing Biosceptres' recent discoveries of the relationship between [...]
Biosceptre attending ASCO 2018
Biosceptre will be attending ASCO 2018 in Chicago. Please contact [...]
Biosceptre presenting a poster at AACR 2018
Biosceptre will be presenting a poster at the American Association [...]
Biosceptre’s Phase 1 Clinical Trial for anti-cancer vaccine BIL06v approved by Ethics Committee
On the 21st of February Biosceptre's proposed Phase I clinical [...]
Biosceptre welcomes Tuspark S & T into its Series A fund raising round
Biosceptre has received over £8M into its’ series A raise [...]